STATE STREET CORP - TRANSPHORM INC ownership

TRANSPHORM INC's ticker is TGAN and the CUSIP is 89386L100. A total of 40 filers reported holding TRANSPHORM INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of TRANSPHORM INC
ValueSharesWeighting
Q3 2023$902,048
-31.7%
406,328
+4.6%
0.00%
Q2 2023$1,320,655
+36.3%
388,428
+60.0%
0.00%
Q1 2023$968,760
-63.3%
242,797
-50.0%
0.00%
Q4 2022$2,641,632
+119.0%
485,594
+102.6%
0.00%
Q3 2022$1,206,000
+55.0%
239,734
+17.4%
0.00%
Q2 2022$778,000204,2800.00%
Other shareholders
TRANSPHORM INC shareholders Q3 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 4,619,558$10,255,4194.85%
Kohlberg Kravis Roberts & Co. L.P. 22,675,980$50,340,6761.77%
Worth Venture Partners, LLC 1,152,278$2,558,0571.52%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 250,084$555,1870.78%
Black Maple Capital Management LP 63,923$141,9090.10%
Taylor Frigon Capital Management LLC 62,500$138,7500.08%
Polar Asset Management Partners Inc. 1,009,702$2,241,5380.05%
Soros Fund Management 340,000$754,8000.01%
AMERIPRISE FINANCIAL INC 4,443,329$9,864,1910.00%
Stratos Wealth Partners, LTD. 25,640$56,9210.00%
View complete list of TRANSPHORM INC shareholders